Indivior PLC (INDV)
32.97
-0.57 (-1.70%)
Inactive · Last trade price on Jan 23, 2026
Indivior Employees
Indivior had 1,000 employees as of June 30, 2025. The number of employees did not change compared to the same quarter last year.
Employees
1,000
Change
n/a
Growth
n/a
Revenue / Employee
$1,180,000
Profits / Employee
$124,000
Market Cap
4.12B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Sep 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Jun 30, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Mar 31, 2024 | 1,000 | 0 | - | 1,000 | 0 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Sep 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Jun 30, 2023 | 1,000 | 100 | 11.11% | 1,000 | 0 |
| Mar 31, 2023 | 1,000 | 200 | 25.00% | 1,000 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Sep 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Jun 30, 2022 | 900 | 100 | 12.50% | 900 | 0 |
| Mar 31, 2022 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Sep 30, 2021 | 800 | 12 | 1.52% | 800 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
INDV News
- 2 days ago - Indivior reports real-world data for Sublocade in opioid use disorder - TheFly
- 2 days ago - New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization - GlobeNewsWire
- 8 days ago - Indivior to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Indivior announces $175M accelerated share repurchase program - TheFly
- 18 days ago - Indivior Announces $175 Million Accelerated Share Repurchase - GlobeNewsWire
- 22 days ago - Indivior reports Q1 EPS 96c, consensus 66c - TheFly
- 22 days ago - Indivior raises FY26 revenue view to $1.22B-$1.29B from $1.13B-$1.2B - TheFly
- 22 days ago - Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance - GlobeNewsWire